<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Low-molecular-weight <z:chebi fb="0" ids="52071">dextran</z:chebi> is utilized by many microsurgeons after free tissue transfer for its beneficial effects on the microcirculation </plain></SENT>
<SENT sid="1" pm="."><plain>While it is generally felt to have a low rate of complications, severe complications secondary to <z:chebi fb="0" ids="52071">dextran</z:chebi>'s osmotic effects may occur </plain></SENT>
<SENT sid="2" pm="."><plain>We report here on two cases in which therapy with low-molecular-weight <z:chebi fb="0" ids="52071">dextran</z:chebi> was strongly implicated as a causative factor in major complications </plain></SENT>
<SENT sid="3" pm="."><plain>These cases and their background are reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>Guidelines for the safe administration of this agent in patients post free-tissue transfer are discussed </plain></SENT>
</text></document>